Shandong Sanyuan Biotechnology Co.,Ltd. (SHE:301206)

Market Cap	5.40B +2.3%
Revenue (ttm)	649.51M -8.9%
Net Income	91.41M -12.9%
EPS	0.46 -11.5%
Shares Out	200.00M
PE Ratio	58.72
Forward PE	n/a
Dividend	1.40 (5.36%)
Ex-Dividend Date	Dec 30, 2025

Volume	2,313,250
Average Volume	1,080,002
Open	25.98
Previous Close	26.10
Day's Range	25.98 - 27.11
52-Week Range	24.50 - 34.69
Beta	0.72
RSI	57.14
Earnings Date	Apr 29, 2026

About SHE:301206

Shandong Sanyuan Biotechnology Co.,Ltd. engages in the research and development, production, and sale of erythritol and compound sugar products in China. Its products are used in table sugar, flavored sugar, and beverages; candy and chocolate food; baked food; health food; medical supplies; cosmetic products; chemical products; and other applications. The company exports its products to Europe, the United States, East Asia, Southeast Asia, Australia, New Zealand, and Africa. Shandong Sanyuan Biotechnology Co.,Ltd. was founded in 2007 and is bas...

• Industry: Confectioners
• Sector: Consumer Staples
• Founded: 2007
• Employees: 436
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301206

Financial Performance

In 2025, SHE:301206's revenue was 649.51 million, a decrease of -8.89% compared to the previous year's 712.90 million. Earnings were 91.41 million, a decrease of -12.90%.